cognitive cybersecurity intelligence

News and Analysis

Why Canada must amend the Controlled Drugs and Substances Act

Canadians suffering from certain mental illnesses may qualify for medical assistance in dying (MAiD) from March 2024. However, federal legislation must be adjusted to allow access to psychedelic-assisted therapies, such as psilocybin, which have shown promise especially for treating treatment-resistant depression. Critics argue it’s paradoxical to permit MAiD without first exploring all potentially life-saving treatments. A recently introduced Special Access Program provides some access to psychedelic therapies with Health Canada approval.

Source: –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts